INTERNATIONAL SOCIETY FOR HEART & … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

GREGORY SCHULTZ

Phone

3122241261

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY FOR HEART & LUNG TRANSPLANTATION, founded in 1981, is a community nonprofit in the Science & Technology sector that reported $7.1M in total revenue in fiscal year 2024. Net assets of $16.4M represent 28 months of operating reserves.

Mission

THE MISSION OF THE SOCIETY IS:1. TO ASSOCIATE PERSONS INTERESTED IN THE FIELDS OF HEART AND LUNG TRANSPLANTATION,END-STAGE HEART AND LUNG DISEASE, AND RELATED SCIENCES.2. TO ENCOURAGE AND STIMULATE BASIC AND CLINICAL RESEARCH IN THESE DISCIPLINES ANDTO PROMOTE NEW THERPEUTIC STRATEGIES.3. TO HOLD SCIENTIFIC MEETINGS FEATURING PRESENTATIONS AND DISCUSSIONS RELEVANT TOTHESE DISCIPLINES.4. TO SPONSOR A SCIENTIFIC JOURNAL FOR THE PUBLICATION OF MANUSCRIPTS RELATED TOTHESE DISCIPLINES.5. TO ESTABLISH AND MAINTAIN AN INTERNATIONAL REGISTRY FOR HEART AND LUNG TRANSPLANTATION.6. TO AWARD RESEARCH GRANTS AND ESTABLISH ENDOWMENTS FOR THE STUDY OF THESEDISCIPLINES.

Program Service Accomplishments

Program 1

Expenses: $3,190,877 Revenue: $4,707,919

ANNUAL MEETING: FOR THE PURPOSE OF SHARING KNOWLEDGE AND ADVANCING PATIENT CARE, THE SOCIETY HOSTS AN ANNUAL GATHERING OF PROFESSIONALS ENGAGED IN THE FIELD OF HEART AND LUNG TRANSPLANTATION...

ANNUAL MEETING: FOR THE PURPOSE OF SHARING KNOWLEDGE AND ADVANCING PATIENT CARE, THE SOCIETY HOSTS AN ANNUAL GATHERING OF PROFESSIONALS ENGAGED IN THE FIELD OF HEART AND LUNG TRANSPLANTATION, END-STAGE HEART AND LUNG DISEASE, AND RELATED SCIENCES. THE MEETING INCLUDES SCIENTIFIC PRESENTATIONS, INVITED LECTURES, AND SYMPOSIA ON TOPICS OF SPECIAL INTEREST.

Program 2

Expenses: $549,105 Revenue: $609,191

JOURNAL: THE SOCIETY PUBLISHES A MONTHLY JOURNAL DEDICATED TO ADVANCES IN THE FIELD OF INTRATHORACIC ORGAN TRANSPLANTATION, SUPPORT, AND REPLACEMENT.

Program 3

Expenses: $354,730

REGISTRY: THE SOCIETY MANAGES TWO TRANSPLANT REGISTRIES, THE INTERNATIONAL REGISTERY FOR MECHANICALLY ASSISTED CIRCULATORY SUPPORT (IMACS) AND THE INTERNATIONAL THORACIC ORGAN TRANSPLANT (TTX)...

REGISTRY: THE SOCIETY MANAGES TWO TRANSPLANT REGISTRIES, THE INTERNATIONAL REGISTERY FOR MECHANICALLY ASSISTED CIRCULATORY SUPPORT (IMACS) AND THE INTERNATIONAL THORACIC ORGAN TRANSPLANT (TTX) REGISTRY. THE REGISTRIES PROMOTE SCIENTIFIC INVESTIGATIONS AND PUBLICATIONS BASED ON ANALYSES OF MULTINATIONAL DATA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $35,766

Program Service Revenue $6,351,424

Investment Income $670,147

Other Revenue $61,055

TOTAL REVENUE $7,118,392

Expense Breakdown

Grants Paid $1,039,000

Salaries & Benefits $1,874,651

Fundraising Expenses $0

Program Expenses $6,396,141

Other Expenses $4,630,042

TOTAL EXPENSES $7,543,693

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,118,392	$6,923,803	+0.0%
Expenses	$7,543,693	$5,723,127	+0.3%
Net Income	$-425,301	$1,200,676	-1.4%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

301

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$592,546

Total Directors

Key Employees

$329,019

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARDI GOMBERG-MAITLAND	TREASURER	1.00	Officer Director	$0	$0	$0
JIGNESH K PATEL	DIRECTOR	1.00	Director	$0	$0	$0
SIMON URSCHEL	DIRECTOR	1.00	Director	$0	$0	$0
MARTA FARRERO TORRES	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTIAN BENDEN	PRESIDENT	1.00	Officer Director	$0	$0	$0
JASON CHRISTIE	PAST PRESIDENT	1.00	Officer Director	$0	$0	$0
MARTIN SCHWEIGER	DIRECTOR	1.00	Director	$0	$0	$0
DIYAR SAEED	DIRECTOR	1.00	Director	$0	$0	$0
PETER M HOPKINS	SECRETARY	1.00	Officer Director	$0	$0	$0
CARON BURCH	DIRECTOR	1.00	Director	$0	$0	$0
DAVID A BARAN	DIRECTOR	1.00	Director	$0	$0	$0
SAIMA ASLAM	DIRECTOR	1.00	Director	$0	$0	$0
HAIFA LYSTER	DIRECTOR	1.00	Director	$0	$0	$0
LAURIE SNYDER	DIRECTOR	1.00	Director	$0	$0	$0
JOSEF STEHLIK	PRESIDENT-ELECT	1.00	Officer Director	$0	$0	$0
YAEL PELED	DIRECTOR	1.00	Director	$0	$0	$0
GREGORY SCHULTZ	CEO	40.00	Officer	$406,502	$31,677	$438,179
AARON ADAIR	COO	40.00	Officer	$134,475	$19,892	$154,367
JACQUELINE SCHWEINZGER	DIRECTOR OF MEETINGS	40.00	Key Emp	$161,915	$6,807	$168,722
SUSAN BESSNER	DIRECTOR OF EDUCATION	40.00	Key Emp	$153,701	$6,596	$160,297
JESSICA BURKE	DIRECTOR OF MARKETING	40.00	Highest	$119,879	$5,116	$124,995

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,118,392	$7,543,693	$19,183,052	$-425,301
2023	$6,923,803	$5,723,127	$19,239,923	$1,200,676
2022	$6,373,232	$5,659,271	$17,334,936	$713,961
2021	$4,949,558	$3,967,612	$16,952,293	$981,946
2020	$2,360,542	$3,310,773	$14,961,655	$-950,231
2019	$6,607,302	$5,483,502	$15,908,480	$1,123,800
2018	$5,705,183	$6,012,710	$13,214,835	$-307,527

INTERNATIONAL SOCIETY FOR HEART & LUNG TRANSPLANTATION